897

FAECAL VOLATILE ORGANIC COMPOUNDS TO DETECT COLORECTAL NEOPLASIA IN LYNCH SYNDROME – A PROSPECTIVE MULTICENTRE STUDY

Date
May 20, 2024

Aims
Colonoscopy surveillance for Lynch syndrome is burdensome and post-colonoscopy colorectal cancer (CRC) still occurs. Non-invasive faecal volatile organic compounds (VOCs) might guide optimal colonoscopy intervals.

Methods
Prospective, multi-centre study in which individuals with Lynch syndrome collected a faecal sample prior to high-quality surveillance colonoscopy. Samples were analysed using field asymmetric ion mobility spectrometry (FAIMS) and our well-established machine learning pipeline including 10-fold cross validation, to assess diagnostic performance of faecal VOC patterns for relevant neoplasia: advanced neoplasia (CRC, advanced adenomas [AA] and advanced serrated lesions [ASL]) and non-advanced adenomas (NAA). On sensitivity analysis, individuals with and without neoplasia were matched 1:1 on possible confounders: gender, age, BMI, smoking and diet. Using gas chromatography time-of-flight mass spectrometry (GC-TOF-MS), individual faecal VOCs were identified from a random subset of 13 NAA and 14 controls.

Results
Of the 132 included individuals (57% female, median age 51y, 86% ≥2 previous colonoscopies), 3 had CRC, 3 AA, 3 ASL and 32 NAA as most relevant neoplasia. Faecal VOC patterns showed a 66% positivity rate and a sensitivity and negative predictive value of, respectively, 100% and 100% for advanced neoplasia (54% specificity), and 88% and 89% for relevant neoplasia (44% specificity). On sensitivity analysis (n=9 versus n=9 [advanced neoplasia], n=35 versus n=35 [relevant neoplasia]), specificity for advanced neoplasia improved to 89% at equal sensitivity (100%) whereas sensitivity for relevant neoplasia decreased to 79% at equal specificity (44%). NAA presence was associated with decreased faecal VOC abundance of butanal, dimethyldisulfide, dimethyltrisulfide, hydrazinecarboxamide and 2-hexanone.
Ranging from extremely burdensome [0] to not burdensome [10], median patient acceptability regarding faeces collection was 7 (IQR 6 – 9), with “not burdensome” being more prevalent among patients under 39y than over 60y irrespective of gender (OR 0.484, p-value 0.045).

Conclusions
Faecal VOC patterns seem to detect relevant neoplasia in Lynch syndrome with high sensitivity and moderate specificity, with the latter potentially improving upon correction for external confounders. Individual faecal VOCs provide pathophysiological insights and, following validation, may be translated into a diagnostic test. These results provide a perspective on faecal VOCs enabling personalised colonoscopy surveillance in Lynch syndrome.

Tracks

Related Products

Thumbnail for RISK STRATIFICATION IN FIT-BASED COLORECTAL CANCER SCREENING: INTERVAL CANCER RISK AFTER THE UPPER AGE LIMIT OF SCREENING HAS BEEN REACHED
RISK STRATIFICATION IN FIT-BASED COLORECTAL CANCER SCREENING: INTERVAL CANCER RISK AFTER THE UPPER AGE LIMIT OF SCREENING HAS BEEN REACHED
Colorectal cancer (CRC) screening programmes have been shown effective in reducing CRC incidence and mortality. Risk stratification offers opportunities for further optimisation of screening programmes by better balancing the harms and benefits of screening…
Thumbnail for COLORECTAL CANCER RISK AFTER POLYP REMOVAL IN FECAL IMMUNOCHEMICAL TEST BASED COLORECTAL CANCER SCREENING
COLORECTAL CANCER RISK AFTER POLYP REMOVAL IN FECAL IMMUNOCHEMICAL TEST BASED COLORECTAL CANCER SCREENING
Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. Due to the presence of co-existent findings at baseline colonoscopy, risk estimation per specific polyp subtype is difficult…
Thumbnail for POST-COLONOSCOPY COLORECTAL CANCERS IN A FIT-BASED CRC SCREENING PROGRAM
POST-COLONOSCOPY COLORECTAL CANCERS IN A FIT-BASED CRC SCREENING PROGRAM
Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. Due to the presence of co-existent findings at baseline colonoscopy, risk estimation per specific polyp subtype is difficult…
Thumbnail for FAECAL IMMUNOCHEMICAL TEST TO DETECT COLORECTAL NEOPLASIA IN LYNCH SYNDROME – A PROSPECTIVE MULTICENTRE STUDY
FAECAL IMMUNOCHEMICAL TEST TO DETECT COLORECTAL NEOPLASIA IN LYNCH SYNDROME – A PROSPECTIVE MULTICENTRE STUDY
Colonoscopy surveillance for Lynch syndrome is burdensome and post-colonoscopy colorectal cancers (CRCs) still occur. The non-invasive faecal immunochemical test (FIT) might guide optimal colonoscopy intervals…